Maziar Khorsandi
Overview
Explore the profile of Maziar Khorsandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin S, Dimarakis I, Minami E, Bakthavatsalam R, Bhattacharya R, Stempien-Otero A, et al.
J Heart Lung Transplant
. 2024 Sep;
44(1):125-128.
PMID: 39222736
For patients with end-stage heart disease and borderline hemodynamics, high human leukocyte antigen allosensitization presents a barrier to heart transplantation in a timely manner. Conventional desensitization protocols are inadequate in...
2.
Yusuff H, Chawla S, Sato R, Dugar S, Bangash M, Antonini M, et al.
J Cardiothorac Vasc Anesth
. 2023 Aug;
37(11):2318-2326.
PMID: 37625918
The right ventricle (RV) is intricately linked in the clinical presentation of critical illness; however, the basis of this is not well-understood and has not been studied as extensively as...
3.
Zochios V, Shelley B, Antonini M, Chawla S, Sato R, Dugar S, et al.
J Cardiothorac Vasc Anesth
. 2023 Jul;
37(10):2073-2086.
PMID: 37393133
No abstract available.
4.
Dimarakis I, Adcox M, Pal J, Khorsandi M
Perfusion
. 2023 Jun;
39(6):1270-1273.
PMID: 37295776
Introduction: Post-infarction ventricular septal defect formation remains a formidable mechanical complication of acute myocardial infarction associated with increased morbidity and mortality. Case Presentation: We describe the case of a 72-year-old...
5.
Dimarakis I, Callan P, Khorsandi M, Pal J, Bravo C, Mahr C, et al.
Front Cardiovasc Med
. 2022 Nov;
9:1029825.
PMID: 36407458
Over the last two decades, implantable continuous flow left ventricular assist devices (LVAD) have proven to be invaluable tools for the management of selected advanced heart failure patients, improving patient...
6.
Bravo C, Navarro A, Dhaliwal K, Khorsandi M, Keenan J, Mudigonda P, et al.
Front Cardiovasc Med
. 2022 Nov;
9:1023549.
PMID: 36337897
Left ventricular assist device (LVAD) therapy is a lifesaving option for patients with medical therapy-refractory advanced heart failure. Depending on the definition, 5-44% of people supported with an LVAD develop...
7.
Khorsandi M, Keenan J, Adcox M, Tabesh A, Badulak J, Pal J, et al.
J Cardiothorac Surg
. 2022 Nov;
17(1):282.
PMID: 36335383
Background: Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) is an effective, but highly resource intensive salvage treatment option in COVID patients with acute respiratory distress syndrome (ARDS). Right ventricular (RV) dysfunction...
8.
Berardi C, Bravo C, Li S, Khorsandi M, Keenan J, Auld J, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407630
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of...
9.
Khorsandi M, Aldea G
Semin Thorac Cardiovasc Surg
. 2021 Jul;
34(3):943-944.
PMID: 34252518
No abstract available.
10.
Farzad K, Khorsandi B, Khorsandi M, Bouamra O, Maknoon R
Sci Total Environ
. 2020 Apr;
725:138422.
PMID: 32298903
Introduction: Air pollution is a global phenomenon which invariably leads to a serious environmental and health related sequalae. "Black carbon" (BC), a subset of fine particulate matter ≤2.5 μm (PM),...